| __timestamp | Celldex Therapeutics, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 3586000 | 11032000 |
| Thursday, January 1, 2015 | 5480000 | 4050000 |
| Friday, January 1, 2016 | 6786000 | 11043000 |
| Sunday, January 1, 2017 | 12743000 | 327000 |
| Monday, January 1, 2018 | 9538000 | 8198000 |
| Tuesday, January 1, 2019 | 3573000 | 35219000 |
| Wednesday, January 1, 2020 | 7418000 | 46551000 |
| Friday, January 1, 2021 | 4651000 | 439442000 |
| Saturday, January 1, 2022 | 2357000 | 722683000 |
| Sunday, January 1, 2023 | 6883000 | 232284000 |
Unleashing the power of data
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and innovation. Over the past decade, Dynavax Technologies Corporation and Celldex Therapeutics, Inc. have showcased contrasting financial trajectories. From 2014 to 2023, Dynavax's revenue surged by an impressive 6,500%, peaking in 2022 with a staggering $723 million. This growth reflects their strategic advancements in vaccine development, particularly during the COVID-19 pandemic.
Conversely, Celldex Therapeutics experienced a more modest revenue increase of approximately 92% over the same period. Their peak revenue in 2017 was $12.7 million, highlighting a steady yet less dramatic growth path. This comparison underscores the varied strategies and market responses within the biotech sector, offering valuable insights into how different companies navigate challenges and opportunities in the ever-evolving healthcare landscape.
Eli Lilly and Company vs Celldex Therapeutics, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Celldex Therapeutics, Inc.?
AstraZeneca PLC or Dynavax Technologies Corporation: Who Leads in Yearly Revenue?
Zoetis Inc. vs Celldex Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Insights: Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation Performance Compared
Comparing Revenue Performance: Ascendis Pharma A/S or Celldex Therapeutics, Inc.?
Revenue Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
Revenue Insights: Grifols, S.A. and Celldex Therapeutics, Inc. Performance Compared
Who Generates More Revenue? Ionis Pharmaceuticals, Inc. or Dynavax Technologies Corporation
Who Generates More Revenue? PTC Therapeutics, Inc. or Dynavax Technologies Corporation
Breaking Down Revenue Trends: Amphastar Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dynavax Technologies Corporation and Celldex Therapeutics, Inc.